Page 425 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C3.2. KQ3 multivariable analyses (continued)
Author Factors Data source Duration Analyzed Population WW/AS Methods Results as described in paper
yr sample characteristics definitions
PMI

Model stratified by number of
comorbidities:
no comorbidities, using WW as the
baseline,
- BT: ≥75 yr vs. <75 yr,
OR=0.165 (CI 0.068, 0.400)
- BT + EBRT: ≥75 yr vs. <75 yr,
OR=0.139 (CI 0.038, 0.516)
- EBRT: ≥75 yr vs. <75 yr,
OR=0.400 (CI 0.178, 0.898)
- PADT: ≥75 yr vs. <75 yr,
OR=0.385 (CI 0.171, 0.866)
- RP: ≥75 yr vs. <75 yr, OR=
0.004 (CI 0.001, 0.015)

See paper for other comorbidity
categories
Results were adjusted for
demographic and risk covariates,
and accruing site.

C-130